BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34980178)

  • 1. Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy.
    Ding Z; Xiang X; Zeng Q; Ma J; Dai Z; Kang K; Bi S
    Radiat Oncol; 2022 Jan; 17(1):1. PubMed ID: 34980178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness.
    He Y; Chen S; Gao X; Fu L; Kang Z; Liu J; Shi L; Li Y
    PLoS One; 2023; 18(1):e0280456. PubMed ID: 36693073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma.
    Lee TF; Chao PJ; Ting HM; Lo SH; Wang YW; Tuan CC; Fang FM; Su TJ
    J Appl Clin Med Phys; 2011 Nov; 12(4):3587. PubMed ID: 22089015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-volume histogram prediction in volumetric modulated arc therapy for nasopharyngeal carcinomas based on uniform-intensity radiation with equal angle intervals.
    Zhuang Y; Han J; Chen L; Liu X
    Phys Med Biol; 2019 Dec; 64(23):23NT03. PubMed ID: 31683261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric comparison between VMAT plans using the fast-rotating O-ring linac with dual-layer stacked MLC and helical tomotherapy for nasopharyngeal carcinoma.
    Ju SG; Ahn YC; Kim YB; Kim JM; Kwon DY; Park BS; Yang K
    Radiat Oncol; 2022 Sep; 17(1):155. PubMed ID: 36096874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
    Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
    World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-institutional investigation into the robustness of intra-cranial multi-target stereotactic radiosurgery plans to delivery errors.
    May L; Hardcastle N; Hernandez V; Saez J; Rosenfeld A; Poder J
    Med Phys; 2024 Feb; 51(2):910-921. PubMed ID: 38141043
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of treatment plan quality for a prototype biology-guided radiotherapy system in the treatment of nasopharyngeal carcinoma.
    Han C; Da Silva AJ; Liang J; Wohlers C; Huntzinger C; Neylon JP; Du D; Wong JYC; Liu A
    Med Dosim; 2021 Summer; 46(2):171-178. PubMed ID: 33272744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy.
    Ning ZH; Mu JM; Jin JX; Li XD; Li QL; Gu WD; Huang J; Han Y; Pei HL
    Radiat Oncol; 2013 Oct; 8():237. PubMed ID: 24125432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma.
    Li S; Zhou Q; Shen LF; Li H; Li ZZ; Yang Z; Lei MJ; Yang XY; Zhang ZJ; Hu YM; Jin ZF; Liu G; Lv ZP; Huang XQ
    Biomed Res Int; 2018; 2018():2653497. PubMed ID: 29967769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of constant dose rate VMAT in the treatment of nasopharyngeal cancer patients.
    Yu W; Shang H; Xie C; Han C; Yi J; Zhou Y; Jin X
    Radiat Oncol; 2014 Nov; 9():235. PubMed ID: 25366034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of automatic VMAT plans in locally advanced nasopharyngeal carcinoma.
    Zhang Q; Ou L; Peng Y; Yu H; Wang L; Zhang S
    Strahlenther Onkol; 2021 Mar; 197(3):177-187. PubMed ID: 32488293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Monte Carlo based robustness calculation and evaluation tool.
    Loebner HA; Volken W; Mueller S; Bertholet J; Mackeprang PH; Guyer G; Aebersold DM; Stampanoni MFM; Manser P; Fix MK
    Med Phys; 2022 Jul; 49(7):4780-4793. PubMed ID: 35451087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer.
    Ding Z; Zeng Q; Kang K; Xu M; Xiang X; Liu C
    Bioengineering (Basel); 2022 Mar; 9(4):. PubMed ID: 35447691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of dose-volume histogram prediction in biologically related models for nasopharyngeal carcinomas treatment planning.
    Cao W; Zhuang Y; Chen L; Liu X
    Radiat Oncol; 2020 Sep; 15(1):216. PubMed ID: 32933543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust optimization in lung treatment plans accounting for geometric uncertainty.
    Zhang X; Rong Y; Morrill S; Fang J; Narayanasamy G; Galhardo E; Maraboyina S; Croft C; Xia F; Penagaricano J
    J Appl Clin Med Phys; 2018 May; 19(3):19-26. PubMed ID: 29524301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.
    Zhang R; Heins D; Sanders M; Guo B; Hogstrom K
    Med Phys; 2018 Jul; 45(7):2912-2924. PubMed ID: 29749075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
    Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
    J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry study of nasopharyngeal carcinoma based on Halcyon accelerator fixed-field intensity-modulated radiation therapy.
    Li K; Li C; Zhu T; Chen J; Cao W; Yin Y; Ma C
    J Cancer Res Ther; 2021 Nov; 17(5):1165-1171. PubMed ID: 34850763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.